U.S. overdose deaths fell nearly 14% in 2025
CDC’s provisional estimate fell to 69,973; opioid-involved deaths also declined.
Article subject labels can be suggestions and are not editorial confirmation.
CDC’s provisional estimate fell to 69,973; opioid-involved deaths also declined.
WHO’s 2026 report estimates 1.34 million viral hepatitis deaths in 2024 and highlights gaps in diagnosis and treatment.
Against its 2018 baseline, WHO’s estimated service coverage rose by 136 million people from 2024.
A joint WHO Europe–ECDC report found 2024 diagnoses covered 79% of estimated disease burden in the region.
New child mortality estimates put neonatal deaths at 2.3 million in 2024 and show slower progress since 2015.
ECDC preliminary data show reports from 30 countries fell from 2024 but remained about twice the 2023 level.
An analysis of 185 countries and 36 cancer types estimates about 7.1 million cases were linked to preventable risks.
By November 2025, 97.1 million people required trachoma interventions, a 94% decline from 2002, WHO said.
The 2025 monitoring report finds progress in service coverage but continued financial hardship for billions.
Prevention tools helped avert an estimated 170 million cases and one million deaths, yet total burden rose.
The Global Tuberculosis Report 2025 shows a modest decline in burden while millions of cases remained undiagnosed.
The 2025 report analyses laboratory data reported in 2023 across 93 pathogen–antibiotic combinations at regional and global levels.